Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Deferred Revenue (2020 - 2024)

Historic Current Deferred Revenue for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q3 2024 value amounting to $600000.0.

  • Rani Therapeutics Holdings' Current Deferred Revenue changed N/A to $600000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $600000.0, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Current Deferred Revenue of $600000.0 as of Q3 2024.
  • In the past 5 years, Rani Therapeutics Holdings' Current Deferred Revenue registered a high of $2.7 million during Q4 2020, and its lowest value of $600000.0 during Q3 2024.